Emotional well-being of heart failure patients and their caregivers.

Abstract:

BACKGROUND:Heart failure (HF) dramatically affects the lives of both patients and their caregivers, yet limited research exists examining the relationship between emotional well-being of HF patients and their caregivers. Therefore, we conducted a study to (1) describe and compare the emotional well-being of HF patients and their caregivers, (2) determine if gender differences exist in emotional well-being of patients and caregivers, and (3) identify factors associated with emotional well-being of HF patients. METHODS:The emotional well-being of 103 patient-caregiver dyads was assessed using the mental health subscale of the SF-12. RESULTS:Patients were 57.6 +/- 12.1 years, predominantly Caucasian (76.7%) and male (67.0%). Caregivers were 59.5 +/- 17.6 years, predominantly females (70.9%) and spouses of patients with HF (82.6%). Patients had significantly lower (poorer) emotional well-being scores than caregivers. Both gender and age were associated with patients' emotional well-being; male and younger participants had higher (better) scores than female and older patients (P <.05). In a multivariate model, patient's age, gender, and caregivers' emotional well-being accounted for 54% of the variance in patients' emotional well-being. CONCLUSION:We found that the emotional well-being of caregivers is associated with the emotional well-being of HF patients. Our findings suggest the need to focus on supporting caregivers and providing them with the strategies they need to support their loved ones with HF.

journal_name

J Card Fail

authors

Evangelista LS,Dracup K,Doering L,Westlake C,Fonarow GC,Hamilton M

doi

10.1054/jcaf.2002.128005

keywords:

subject

Has Abstract

pub_date

2002-10-01 00:00:00

pages

300-5

issue

5

eissn

1071-9164

issn

1532-8414

pii

S1071916402004219

journal_volume

8

pub_type

杂志文章
  • Chronic endothelin blockade in dogs with pacing-induced heart failure: possible modulation of sympathoexcitation.

    abstract:BACKGROUND:Endothelin-1 (ET-1) is a potent vasoconstrictor peptide elaborated by many cell types. Plasma ET-1 levels are significantly augmented in patients and experimental animals with heart failure. Enhanced levels of ET-1 may contribute to myocardial depression and alterations in sympathetic nerve activity in the s...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(00)00012-9

    authors: McConnell PI,Olson CE,Patel KP,Blank DU,Olivari MT,Gallagher KP,Quenby-Brown E,Zucker IH

    更新日期:2000-03-01 00:00:00

  • Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.

    abstract:BACKGROUND:The proinflammatory cytokines have been implicated in the pathogenesis of heart failure. Recent studies have shown that beta-adrenergic blockade can modulate cytokine production. This study investigates the different impact of different degrees of sympathetic antagonism on circulating levels of cytokines in ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2004.07.006

    authors: Cinquegrana G,D'Aniello L,Landi M,Spinelli L,Grande G,De Prisco F,Petretta M

    更新日期:2005-04-01 00:00:00

  • Prognostic Value of Left Atrial Functional Measures in Heart Failure With Reduced Ejection Fraction.

    abstract:BACKGROUND:The prognostic value of LA functional measures in heart failure patients with reduced ejection fraction (HFrEF) is unclear. Therefore, this study investigated the prognostic value of left atrial (LA) functional measures such as the left atrial emptying fraction (LAEF) and the minimal LA volume compared with ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2018.11.016

    authors: Modin D,Sengeløv M,Jørgensen PG,Olsen FJ,Bruun NE,Fritz-Hansen T,Andersen DM,Jensen JS,Biering-Sørensen T

    更新日期:2019-02-01 00:00:00

  • Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.

    abstract:BACKGROUND:We investigated the effects of the dipeptidyl peptidase 4 inhibitor teneligliptin on cardiac function and hemodynamics during heart failure in hypertensive model rats. METHODS AND RESULTS:Fifty-five male Dahl salt-sensitive rats were divided into 4 groups: control group (0.3% NaCl chow; n = 13), hypertensio...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2017.09.001

    authors: Yamamoto M,Ishizu T,Seo Y,Suto Y,Sai S,Xu D,Murakoshi N,Kimura T,Kawakami Y,Aonuma K

    更新日期:2018-01-01 00:00:00

  • The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction.

    abstract:BACKGROUND:Studies have identified anemia as a potential therapeutic target in patients with heart failure, with the goal of improving survival and health status. However, whether changes in hematocrit are associated with changes in health status is unknown. METHODS AND RESULTS:We studied 1382 patients with heart fail...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2007.09.009

    authors: Kosiborod M,Krumholz HM,Jones PG,Pitt B,Spertus JA

    更新日期:2008-02-01 00:00:00

  • Serum pregnancy-associated plasma protein a in patients with heart failure.

    abstract:BACKGROUND:Pregnancy-associated plasma protein A (PAPP-A) proteolyzes insulin-like growth factor (IGF)-binding proteins and thus increases IGF-1 bioactivity. PAPP-A has been reported to be involved in various pathophysiologic abnormalities; however, the clinical significance of PAPP-A has not been examined in cases of ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2011.05.011

    authors: Funayama A,Shishido T,Netsu S,Ishino M,Sasaki T,Katoh S,Takahashi H,Arimoto T,Miyamoto T,Nitobe J,Watanabe T,Kubota I

    更新日期:2011-10-01 00:00:00

  • Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

    abstract:BACKGROUND:Disease-modifying drug treatment in heart failure (HF) reduces blood pressure. Titration of these agents is guided by clinic blood pressure readings; however, the impact of such treatment on blood pressure is unknown because diurnal blood pressure patterns remain poorly described. The aim of this study was t...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.03.003

    authors: Mak G,Murphy NF,Ali A,Walsh A,O'Loughlin C,Conlon C,McCaffrey D,Ledwidge M,McDonald K

    更新日期:2008-09-01 00:00:00

  • Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study.

    abstract:BACKGROUND:We examined the accuracy of Medicare heart failure (HF) diagnostic codes in the identification of acute decompensated (ADHF and chronic stable (CSHF) HF. METHODS AND RESULTS:Hospitalizations were identified from medical discharge records for Atherosclerosis Risk in Communities (ARIC) study participants with...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.07.013

    authors: Kucharska-Newton AM,Heiss G,Ni H,Stearns SC,Puccinelli-Ortega N,Wruck LM,Chambless L

    更新日期:2016-01-01 00:00:00

  • Peripheral Intravenous Volume Analysis (PIVA) for Quantitating Volume Overload in Patients Hospitalized With Acute Decompensated Heart Failure-A Pilot Study.

    abstract:BACKGROUND:To determine the feasibility of peripheral intravenous volume analysis (PIVA) of venous waveforms for assessing volume overload in patients admitted to the hospital with acute decompensated heart failure (ADHF). METHODS:Venous waveforms were captured from a peripheral intravenous catheter in subjects admitt...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2018.05.003

    authors: Miles M,Alvis BD,Hocking K,Baudenbacher F,Guth C,Lindenfeld J,Brophy C,Eagle S

    更新日期:2018-08-01 00:00:00

  • Relationship between pulmonary capillary wedge V wave and transmitral and pulmonary venous flow velocity patterns in various heart diseases.

    abstract:BACKGROUND:A large V wave in a pulmonary capillary wedge pressure (PCWP) tracing is characteristic of mitral regurgitation. However, the V wave is often increased in patients without or with no significant mitral regurgitation. METHODS AND RESULTS:The V wave was in the PCWP tracing investigated in 65 patients using tr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(96)80044-3

    authors: Kageji Y,Oki T,Iuchi A,Tabata T,Ito S

    更新日期:1996-09-01 00:00:00

  • Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support.

    abstract:BACKGROUND:Aortic insufficiency (AI) is associated with morbidity and mortality in patients with continuous-flow left ventricular assist devices (LVADs), whereas its impact on the HeartMate 3 LVAD cohorts remains uninvestigated. We aimed to investigate the clinical impact of AI on patients with HeartMate 3 LVADs. METH...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.05.013

    authors: Imamura T,Narang N,Kim G,Nitta D,Fujino T,Nguyen A,Grinstein J,Rodgers D,Ota T,Jeevanandam V,Sayer G,Uriel N

    更新日期:2020-10-01 00:00:00

  • Design of an acute dP/dt hemodynamic measurement protocol to isolate cardiac effect of pacing.

    abstract:BACKGROUND:Invasively measured maximum increase in left ventricular pressure (LV dP/dtmax) has been used to assess biventricular (BiV) pacing. We quantified extracardiac factors contributing to its variability, and developed a protocol to minimize these effects in an acute pacing experiment. METHODS AND RESULTS:Contin...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.01.020

    authors: Thibault B,Dubuc M,Karst E,Andrade J,Dyrda K,Guerra PG,Macle L,Rivard L,Roy D,Talajic M,Ryu K,Farazi TG,Varma N,Khairy P

    更新日期:2014-05-01 00:00:00

  • Heart Failure With Midrange Ejection Fraction in Patients Admitted for Acute Decompensation: A Report from the Japanese Multicenter Registry.

    abstract:BACKGROUND:Patients having heart failure with midrange ejection fraction (HFmrEF: 40% ≤ EF < 50%) are increasingly being considered a new subset of the population with heart failure. Despite recent advances in heart-failure treatment strategies, the prognosis of these patients has not improved substantially over time. ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2019.05.010

    authors: Takei M,Kohsaka S,Shiraishi Y,Goda A,Nagatomo Y,Mizuno A,Suzino Y,Kohno T,Fukuda K,Yoshikawa T

    更新日期:2019-08-01 00:00:00

  • Soluble Receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure.

    abstract:BACKGROUND:We recently reported that serum levels of pentosidine, one of the well-defined advanced glycation end products (AGE), was an independent prognostic factor for heart failure. Receptor for AGEs (RAGE) is expressed in a variety of tissues, and RAGE has a C-truncated secretory isoform of the receptor protein, te...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2007.10.019

    authors: Koyama Y,Takeishi Y,Niizeki T,Suzuki S,Kitahara T,Sasaki T,Kubota I

    更新日期:2008-03-01 00:00:00

  • Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure?

    abstract::Stimulation of the V1a receptor for arginine vasopressin produces myocardial and vascular effects similar to those of angiotensin II while stimulation of the V2 receptor causes fluid retention. There are no data with sustained blockade of the V1a receptor while single-dose experiments suggest benefit. Acute and chroni...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2017.12.011

    authors: Goldsmith SR,Udelson JE,Gheorghiade M

    更新日期:2018-02-01 00:00:00

  • Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.

    abstract::Diuretic resistance in heart failure is defined as a state in which diuretic response is diminished or lost before the therapeutic goal of relief from congestion has been reached. Diuretic resistance is very common and is associated with poor outcomes. Over the past decade, several new drugs and devices targeting deco...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2014.06.353

    authors: Liu C,Liu K

    更新日期:2014-09-01 00:00:00

  • Influence of rapid fluid loading on airway structure and function in healthy humans.

    abstract:BACKGROUND:The present study examined the influence of rapid intravenous fluid loading (RFL) on airway structure and pulmonary vascular volumes using computed tomography imaging and the subsequent impact on pulmonary function in healthy adults (n = 16). METHODS AND RESULTS:Total lung capacity (DeltaTLC = -6%), forced ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.08.005

    authors: Ceridon ML,Snyder EM,Strom NA,Tschirren J,Johnson BD

    更新日期:2010-02-01 00:00:00

  • Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis.

    abstract:BACKGROUND:The role of matrix metalloproteinases (MMPs) polymorphisms on heart failure (HF) susceptibility, phenotypic characteristics, and prognosis has been poorly explored. METHODS AND RESULTS:We studied 313 HF patients with left ventricular systolic dysfunction and 367 healthy control subjects. Genotyping of MMP-1...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.09.017

    authors: Velho FM,Cohen CR,Santos KG,Silvello D,Martinelli N,Biolo A,Clausell N,Rohde LE

    更新日期:2011-02-01 00:00:00

  • Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers.

    abstract:BACKGROUND:Peak oxygen consumption (VO(2)) is an important criterion for listing patients for cardiac transplantation. Beta-blockers improve survival without affecting peak VO(2). We questioned the value of peak VO(2) in predicting outcome in patients treated with beta-blockers. METHODS AND RESULTS:We reviewed the rec...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(03)00593-1

    authors: Shakar SF,Lowes BD,Lindenfeld J,Zolty R,Simon M,Robertson AD,Bristow MR,Wolfel EE

    更新日期:2004-02-01 00:00:00

  • Quality assurance and cardiopulmonary exercise testing in clinical trials.

    abstract:BACKGROUND:Peak oxygen uptake (VO2) measured during cardiopulmonary exercise testing (CPX) is often used as an outcome measure in clinical trials. The purposes of this study are (a) to report the outcomes of a quality assurance (QA) procedure instituted in multisite clinical trials by a CPX data core laboratory and (b)...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.01.001

    authors: Brawner CA,Ehrman JK,Aldred H,Schairer JR,Keteyian SJ

    更新日期:2008-05-01 00:00:00

  • Validation of a risk score for dying within 1 year of an admission for heart failure.

    abstract:BACKGROUND:Development of heart failure greatly reduces life expectancy. Accurate estimates of the risk of dying are needed in clinical practice and for risk adjustment in observational studies. A relatively simple risk score has been developed to determine the risk of dying within 1-year of an admission for heart fail...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.02.004

    authors: Rector TS,Ringwala SN,Ringwala SN,Anand IS

    更新日期:2006-05-01 00:00:00

  • Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure.

    abstract::Clinical trials designed to evaluate the effect of drugs and devices on the symptoms and clinical status in chronic heart failure have frequently produced conflicting, inconclusive, or misleading results. These difficulties can be explained by the fact that previous studies have relied on efficacy measures that have i...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2001.25652

    authors: Packer M

    更新日期:2001-06-01 00:00:00

  • Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

    abstract:BACKGROUND:Genetic heterogeneity at the endothelial nitric oxide synthase (NOS3) locus influences heart failure outcomes. The prevalence of NOS3 variants differs in black and white cohorts, but the impact of these differences is unknown. METHODS AND RESULTS:Subjects (n = 352) in the Genetic Risk Assessment of Heart Fa...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2008.10.028

    authors: McNamara DM,Tam SW,Sabolinski ML,Tobelmann P,Janosko K,Venkitachalam L,Ofili E,Yancy C,Feldman AM,Ghali JK,Taylor AL,Cohn JN,Worcel M

    更新日期:2009-04-01 00:00:00

  • Age, but not sex, influences the measurement of ejection fraction in elderly patients hospitalized for heart failure.

    abstract:BACKGROUND:Current US and European guidelines recommend that ejection fraction (EF) be measured at least once in patients with congestive heart failure (CHF). However, it is not known how age and sex influence adherence to this recommendation. METHODS:We reviewed a national sample of Medicare patients discharged with ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2003.16

    authors: Lindenfeld J,Fiske KS,Stevens BR,Debuhr J,Havranek EP,Abrams FR

    更新日期:2003-04-01 00:00:00

  • Incident Heart Failure and Cognitive Decline: The Atherosclerosis Risk in Communities Study.

    abstract:BACKGROUND:Cognitive impairment is found in a significant proportion of patients with heart failure (HF). Although cognitive impairment may be a consequence of HF, early signs of cognitive impairment may also indicate subclinical vascular disease, and thus a risk factor for future cardiovascular events. METHODS AND RE...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2016.11.002

    authors: Bressler J,Knopman DS,Sharrett AR,Gottesman RF,Penman A,Chang PP,Rosamond WD,Boerwinkle E,Mosley TH

    更新日期:2017-01-01 00:00:00

  • Treatment of heart failure according to William Stokes: the enchanted mercury.

    abstract:BACKGROUND:It was not until 1919 that the diuretic properties of mercury were observed in patients with syphilis; in the same year the beneficial effects of mercurial diuretics were shown in a patient with severe rheumatic heart disease and anasarca. However, mercury had been used much earlier for the treatment of drop...

    journal_title:Journal of cardiac failure

    pub_type: 传,历史文章,杂志文章

    doi:10.1054/jcaf.2001.26564

    authors: Ventura HO,Mehra MR,Young JB

    更新日期:2001-09-01 00:00:00

  • Quality of care and hospital readmission in congestive heart failure: an explicit review process.

    abstract:BACKGROUND:The effect of hospital quality of care on hospital readmission for patients with congestive heart failure (CHF) has not been widely studied. METHODS AND RESULTS:We examined the effects of clinical factors, hospital quality of care, and cardiologist involvement on 3-month readmission rates in patients with C...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2001.28931

    authors: Polanczyk CA,Newton C,Dec GW,Di Salvo TG

    更新日期:2001-12-01 00:00:00

  • Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.

    abstract:BACKGROUND:In patients with heart failure and preserved ejection fraction (HF-PEF) randomized in the Americas as part of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, treatment with spironolactone enhanced the risk of hyperkalemia but reduced the risk of hypoka...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2018.03.002

    authors: Desai AS,Liu J,Pfeffer MA,Claggett B,Fleg J,Lewis EF,McKinlay S,O'Meara E,Shah SJ,Sweitzer NK,Solomon S,Pitt B

    更新日期:2018-05-01 00:00:00

  • Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.

    abstract:BACKGROUND:Cachexia in chronic heart failure carries a poor prognosis, but little is known about the influence of body mass on the prognosis of noncachectic heart failure patients. METHODS:We studied 589 consecutive chronic heart failure patients followed for at least a year, in whom there were accurate baseline data ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2003.4

    authors: Davos CH,Doehner W,Rauchhaus M,Cicoira M,Francis DP,Coats AJ,Clark AL,Anker SD

    更新日期:2003-02-01 00:00:00

  • Cardiac myocyte remodeling in hypertrophy and progression to failure.

    abstract::Contracting myocytes are highly variable in size and generally resemble elliptical cylinders in shape. Although their arrangement within the ventricular wall is rather complex, their length runs in a tangential manner, and their transverse axis runs transmurally. Consequently, it was proposed many years ago that chang...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2002.129280

    authors: Gerdes AM

    更新日期:2002-12-01 00:00:00